GB202020553D0 - Antagonist of pcsk9 - Google Patents

Antagonist of pcsk9

Info

Publication number
GB202020553D0
GB202020553D0 GBGB2020553.0A GB202020553A GB202020553D0 GB 202020553 D0 GB202020553 D0 GB 202020553D0 GB 202020553 A GB202020553 A GB 202020553A GB 202020553 D0 GB202020553 D0 GB 202020553D0
Authority
GB
United Kingdom
Prior art keywords
pcsk9
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2020553.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argonaute RNA Ltd
Original Assignee
Argonaute RNA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argonaute RNA Ltd filed Critical Argonaute RNA Ltd
Priority to GBGB2020553.0A priority Critical patent/GB202020553D0/en
Publication of GB202020553D0 publication Critical patent/GB202020553D0/en
Priority to CA3167849A priority patent/CA3167849A1/en
Priority to EP21712703.4A priority patent/EP4081642A1/en
Priority to PCT/EP2021/056540 priority patent/WO2021185765A1/en
Priority to JP2022552336A priority patent/JP2023519140A/en
Priority to US17/908,225 priority patent/US20230183694A1/en
Priority to CN202180013447.0A priority patent/CN115066498A/en
Priority to GB2103594.4A priority patent/GB2594788B/en
Ceased legal-status Critical Current

Links

GBGB2020553.0A 2020-03-16 2020-12-23 Antagonist of pcsk9 Ceased GB202020553D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB2020553.0A GB202020553D0 (en) 2020-12-23 2020-12-23 Antagonist of pcsk9
CA3167849A CA3167849A1 (en) 2020-03-16 2021-03-15 Antagonist of pcsk9
EP21712703.4A EP4081642A1 (en) 2020-03-16 2021-03-15 Antagonist of pcsk9
PCT/EP2021/056540 WO2021185765A1 (en) 2020-03-16 2021-03-15 Antagonist of pcsk9
JP2022552336A JP2023519140A (en) 2020-03-16 2021-03-15 PCSK9 antagonist
US17/908,225 US20230183694A1 (en) 2020-03-16 2021-03-15 Antagonist of pcsk9
CN202180013447.0A CN115066498A (en) 2020-03-16 2021-03-15 Antagonists of PCSK9
GB2103594.4A GB2594788B (en) 2020-03-16 2021-03-16 Antagonist of PCSK9

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2020553.0A GB202020553D0 (en) 2020-12-23 2020-12-23 Antagonist of pcsk9

Publications (1)

Publication Number Publication Date
GB202020553D0 true GB202020553D0 (en) 2021-02-03

Family

ID=74221044

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2020553.0A Ceased GB202020553D0 (en) 2020-03-16 2020-12-23 Antagonist of pcsk9

Country Status (1)

Country Link
GB (1) GB202020553D0 (en)

Similar Documents

Publication Publication Date Title
GB2594788B (en) Antagonist of PCSK9
IL277127A (en) Use of pcsk9 inhibitor for reducing cardiovascular risk
IL279363A (en) Pcsk9 antagonist compounds
IL281939A (en) Inhibitors of vap-1
EP4069212A4 (en) Inhibitors of hif-2alpha
IL284640A (en) Pcsk9 inhibitors and methods of use thereof
IL287751A (en) Kcnt1 inhibitors and methods of use
SG11202112158YA (en) Kcnt1 inhibitors and methods of use
IL284661A (en) Pcsk9 inhibitors and methods of use thereof
IL310992A (en) Inhibitors of nlrp3
EP4076492A4 (en) Pcsk9 antagonist compounds
IL292860A (en) Allosteric egfr inhibitors and methods of use thereof
IL281815A (en) Inhibitors of vap-1
SG11202109781QA (en) Uses of phosphodiesterase inhibitors
GB201810746D0 (en) Use of sclerostin antagonist
GB202113104D0 (en) Antagonist of pcsk9
GB202020553D0 (en) Antagonist of pcsk9
GB202013998D0 (en) Antagonist of pcsk9
GB202003756D0 (en) Antagonist of PCSK9
EP4317153A4 (en) Abhd6 antagonist
GB2589398B (en) Compounds and methods of use
GB202215863D0 (en) Preparation of neosaxitoxin
ZA202105399B (en) Use of spiropidion
EP3968994C0 (en) Abhd12 inhibitors and methods of making and using same
GB202010276D0 (en) PCSK9 antagonist

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)